Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
In this study, the effect of patient education on reported bone pain in breast cancer
patients receiving adjuvant or neoadjuvant chemotherapy and pegfilgrastim will be
investigated.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Maximum subject-reported bone pain in cycle 1
To estimate the difference between arms in mean maximum severity of subject-reported bone pain in cycle 1
up to 20 weeks
No
MD
Study Director
Amgen
United States: Institutional Review Board
20110148
NCT01752907
January 2013
May 2014
Name | Location |
---|---|
Research Site | Anaheim, California |
Research Site | Boca Raton, Florida |
Research Site | Arlington Heights, Illinois |
Research Site | Ames, Iowa |
Research Site | Beverly, Massachusetts |
Research Site | Branson, Missouri |
Research Site | Hooksett, New Hampshire |
Research Site | Belleville, New Jersey |
Research Site | Albuquerque, New Mexico |
Research Site | Albany, New York |
Research Site | Asheville, North Carolina |
Research Site | Akron, Ohio |
Research Site | Bend, Oregon |
Research Site | Chattanooga, Tennessee |
Research Site | Abington, Virginia |